No Data
No Data
Kyowa Kirin's Rare Disease Therapy Becomes World's Most Expensive Drug
13 Best Biotech Stocks To Buy Under $20
AMD To Rally Around 16%? Here Are 10 Top Analyst Forecasts For Monday
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page. B of A Sec
UniQure Is Maintained at Neutral by Mizuho
UniQure Is Maintained at Neutral by Mizuho
Express News | Mizuho Maintains Neutral on UniQure, Lowers Price Target to $7
Earnings Update: UniQure N.V. (NASDAQ:QURE) Just Reported And Analysts Are Trimming Their Forecasts
It's been a mediocre week for uniQure N.V. (NASDAQ:QURE) shareholders, with the stock dropping 12% to US$5.59 in the week since its latest full-year results. Revenues were a bright spot, with US
No Data